Vancouver, Canada

Clement Leung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Clement Leung in Automated Sperm Manipulation

Introduction

Clement Leung is an innovative inventor based in Vancouver, Canada. He has made significant contributions to the field of reproductive technology, particularly through his patented methods and devices for sperm manipulation.

Latest Patents

Clement Leung holds a patent for a "Method for automated sperm manipulation and device for holding sperm and oocytes." This invention relates to systems and methods for automated, computer-controlled tracking and manipulation of motile specimens. The technology is particularly suited for Intracytoplasmic Sperm Injection (ICSI) procedures. The device comprises a sealed chamber with an air outlet, one well for motile cells, such as sperm, and another well for non-motile cells, such as oocytes. He has 1 patent to his name.

Career Highlights

Throughout his career, Clement has focused on advancing reproductive technologies. His work has the potential to improve the success rates of assisted reproductive techniques, making a significant impact in the field.

Collaborations

Clement has collaborated with notable colleagues, including Yu Sun and Zhe Lu. Their combined expertise has contributed to the development of innovative solutions in reproductive health.

Conclusion

Clement Leung's contributions to automated sperm manipulation highlight his role as a forward-thinking inventor in reproductive technology. His work continues to pave the way for advancements in assisted reproductive techniques.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…